|
WO2021036803A1
|
|
Use of long-acting protein preparation for improving sexual dysfunction
|
|
WO2019184370A1
|
|
Method for removing n-terminal truncated and abnormal variants in rhngf
|
|
WO2019184366A1
|
|
Method for dynamically removing recombinant human nerve growth factor precursor by hydrophobic interaction chromatography
|
|
US2020385477A1
|
|
Gene combination capable of high-efficiency expression of recombinant human nerve growth factor
|
|
WO2019184368A1
|
|
Method for preparing highly pure rhngf
|
|
WO2019184373A1
|
|
Intron for increasing expression level of rhngf
|
|
WO2019056926A1
|
|
Reagent for rapidly and quantitatively detecting antimicrobial susceptibility and application method thereof
|
|
WO2019056927A1
|
|
Method and biological indicator for rapidly determining sterilization effect
|
|
CN103820310A
|
|
Concentration gradient detection kit for drug sensitivity tests and measuring method thereof
|
